Tricuspid Valve #4: TR Physiology

Tricuspid regurgitation (TR) is not simply “leakage across the valve.” It is a right-heart volume–pressure interaction that evolves into a self-amplifying cycle of annular dilation, leaflet malcoaptation, RA/RV remodeling, systemic venous congestion, and reduced forward cardiac output—often long before the RV “looks” severely dysfunctional on routine metrics [1,6,7].

1) Core hemodynamic event: systolic backflow (RV → RA)

• Primary event: During RV systole, an incompetent tricuspid valve permits regurgitant flow into the RA, reducing effective forward flow to the pulmonary circulation [6,7].
• Why severity escalates: Mild TR may be buffered by RA compliance and low right-sided pressures, but increasing regurgitant fraction imposes a chronic volume burden that drives structural remodeling [6,7].
• Key physiologic consequence: The RV must handle total stroke volume = forward SV + regurgitant SV, so RV volume overload becomes a dominant engine of progression [6,7].

2) Remodeling cascade: RA dilation → annular dilation → RV dilation (± tethering)

TR progression is best understood as a geometry failure rather than a purely “leaflet problem.”

A. RA dilation (atrial-driven remodeling)

• Chronic regurgitant inflow and elevated RA pressure enlarge the RA, promoting annular enlargement and loss of the annulus’ sphincter-like function [2,9].
• In patients with atrial fibrillation (AF), RA remodeling strongly tracks annular enlargement; RA minimum volume has been shown to be a powerful independent predictor of tricuspid annular area on 3D echocardiography [2].

B. Dynamic annular dilation (load-dependent)

• The tricuspid annulus is dynamic: it enlarges and becomes more planar as right-sided volume/pressure rise, reducing coaptation reserve and making TR more load-sensitive (and often exercise-provocable) [6,7].
• This “dynamic annulus” concept is clinically important because TR severity may be underestimated at rest and worsen with physiologic stress [6,7].

C. RV dilation and functional tethering (ventricular-driven remodeling)

• RV enlargement displaces the subvalvular apparatus (papillary muscles/chordae), increasing tethering height/area and pulling leaflets apically and laterally—producing malcoaptation even when leaflet tissue is intrinsically normal [3,6].
• Quantitatively, tethering height correlates with TR severity in functional TR cohorts, supporting tethering as a measurable mechanism rather than a qualitative impression [3].

Clinical translation

• The combination of annular dilation + leaflet tethering converts a potentially reversible functional lesion into a more fixed geometric problem, creating self-perpetuating TR [1,3,6].

3) Two functional TR phenotypes: atrial functional TR vs ventricular functional TR

Modern datasets support two dominant functional phenotypes with different remodeling patterns and implications for repair durability and prognosis:

A. Atrial functional TR (AF-TR / atrial secondary TR)

• Mechanism: RA dilation + annular dilation (often with AF), relatively less leaflet tethering early [1,2,9].
• 3D echo phenotype: larger annular dimensions with comparatively less subvalvular displacement, in contrast to ventricular phenotypes [1].
• Clinical signal: AF-TR is not benign; it is associated with adverse outcomes in several cohorts, emphasizing that “isolated” TR can be a marker of advanced atrial/right-heart disease rather than a trivial bystander [4,5].

B. Ventricular functional TR (VF-TR / ventricular secondary TR)

• Mechanism: RV remodeling (often driven by pulmonary hypertension, LV disease, or RV pressure/volume loading) with more prominent leaflet tethering and papillary displacement [1,3,6].
• 3D echo phenotype: greater tethering geometry and apical displacement patterns consistent with ventricular remodeling [1,3].

This atrial–ventricular mechanistic framing complements morphologic classifications of TR and helps map physiology to intervention strategy [6,8].

4) Why outcomes are often “systemic” rather than “pulmonary”

Severe TR behaves as systemic venous disease + low-output physiology.

A. Systemic venous congestion (backward failure)

• Elevated RA pressure transmits to the venous system, producing:
• Congestive hepatopathy (hepatic congestion),
• Ascites
• Peripheral edema
• Renal venous congestion → reduced renal perfusion and diuretic resistance (late phenotype) [6,7].

B. Reduced forward flow (forward failure): ventricular interdependence

Even if the RV appears “hyperdynamic,” effective forward flow can fall because regurgitant volume steals stroke volume [6,7]. A high-yield physiologic summary is:

• “The RV cannot fill the LV.”

Mechanistically:

• RV dilation and pressure loading shift the interventricular septum leftward, restricting LV diastolic filling (ventricular interdependence).
• Reduced LV preload translates into low systemic cardiac output (exercise intolerance, fatigue, limited CO reserve) [6,7].

5) Rhythm is not a bystander: TR ↔ AF as a reinforcement loop

• RA stretch promotes AF/flutter, and AF accelerates RA dilation and annular enlargement—amplifying TR [2,9].
• In HFpEF, RA remodeling–linked functional TR (atrial phenotype) has been associated with substantially increased heart failure hospitalization risk, underscoring that rhythm/atrial disease often defines the clinical trajectory [4].
• Contemporary definitions for atrial TR incorporate limited tethering and preserved ventricular dimensions to separate atrial-driven TR from ventricular-driven TR, and these definitions carry prognostic implications [5].

6) Practical “vicious-cycle” model (what to teach, what to treat)

A durable teaching model is a closed loop:

• TR → RA/RV volume overload → annular dilation → malcoaptation/tethering → worse TR [1,3,6]
• TR → systemic venous congestion (liver/ascites/edema) [6,7]
• TR → ventricular interdependence → ↓ LV filling → low systemic output [6,7]
• TR ↔ AF → further RA/annular remodeling [2,5,9]

Intervention logic

• Outcomes improve when treatment occurs before:
• marked RV dilation and severe tethering geometry dominate [1,3],
• end-organ congestion becomes advanced [6,7],
• AF-driven atrial remodeling becomes irreversible [2,5].

7) Surgical/structural “decision hooks” (evidence-aligned)

When translating physiology into an operative or transcatheter plan, prioritize:

1. Annulus
• Size and dynamic behavior; atrial remodeling can be the primary annular driver [1,2].
2. Leaflet coaptation reserve
• Coaptation gap and tethering; tethering metrics correlate with TR severity and often predict recurrence risk if only annular reduction is performed [3,6].
3. RV function and RV–PA coupling
• TR can mask true RV contractile impairment by unloading the RV; interpret RV function with geometry, afterload, and coupling in mind [6,7].

References

[1] Utsunomiya H, Harada Y, Susawa H, et al. Tricuspid valve geometry and right heart remodelling in atrial functional tricuspid regurgitation. Eur Heart J Cardiovasc Imaging. 2020;21(10):1068-1078.

[2] Guţă AC, Badano LP, Tomaselli M, et al. The Pathophysiological Link between Right Atrial Remodeling and Functional Tricuspid Regurgitation in Patients with Atrial Fibrillation: A Three-Dimensional Echocardiography Study. J Am Soc Echocardiogr. 2021;34(6):585-594.e1.

[3] Fukuda S, Gillinov AM, Song JM, Daimon M, Kongsaerepong V, Thomas JD, Shiota T. Echocardiographic insights into atrial and ventricular mechanisms of functional tricuspid regurgitation. Am Heart J. 2006;152(6):1208-1214.

[4] Harada T, Obokata M, Omote K, et al. Functional Tricuspid Regurgitation and Right Atrial Remodeling in Heart Failure With Preserved Ejection Fraction. Am J Cardiol. 2022;162:129-135.

[5] Schlotter F, Dietz MF, Stolz L, et al. Atrial Functional Tricuspid Regurgitation: Novel Definition and Impact on Prognosis. Circ Cardiovasc Interv. 2022;15(9):e011958.

[6] Prihadi EA, Delgado V, Leon MB, et al. Morphologic Types of Tricuspid Regurgitation: Characteristics and Prognostic Implications. JACC Cardiovasc Imaging. 2019;12(3):491-499.

[7] Topilsky Y. Tricuspid valve regurgitation: epidemiology and pathophysiology. Minerva Cardioangiol. 2018;66(6):673-679.

[8] Gavazzoni M, Badano LP, Vizzardi E, et al. The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype. Front Cardiovasc Med. 2022;9:1022755.

[9] Florescu DR, Muraru D, Volpato V, et al. Atrial Functional Tricuspid Regurgitation as a Distinct Pathophysiological and Clinical Entity: No Idiopathic Tricuspid Regurgitation Anymore. J Clin Med. 2022;11(2):382.